GlassScriptPhysician profile
Alexander Axelrad
NPI 1306934690
$956.12
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.34 · 2022: $642 · 2023: $196 · 2024: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.18 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $306.75 | 2022 | |
| Haemonetics Corporation | $229.35 | 2022-2024 | Teg6s Hemostasis System |
| Osteomed LLC | $97.34 | 2022 | |
| Kerecis Limited | $87.02 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Astrazeneca Pharmaceuticals LP | $70.06 | 2022-2024 | Andexxa |
| Csl Behring | $50.61 | 2023 | Kcentra |
| Smith+Nephew, INC. | $24.30 | 2022 | |
| Kci USA, INC. | $24.01 | 2023 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Becton, Dickinson and Company | $21.51 | 2022 | |
| Avita Medical Americas, LLC | $17.66 | 2023 | Recell |
| Zimmer Biomet Holdings, INC. | $17.17 | 2022 | |
| Z-Medica, LLC | $10.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Axelrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.